Delivery Order SPE2DB20D3303-SPE2DB23FZ3S9

Award Date 4/17/23
Potential Completion Date 4/18/23
Potential Value $6.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,371.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a pharmaceutical product, with a completion date of September 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was awarded on September 26, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of TELMISARTAN 40 MG TABLET 30S. The contract has a ceiling value of $3,554.38 and a completion date of October 24, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type for the supply of 4562954747 - TELMISARTAN 20 MG TABLET 30S, with an ultimate completion date of December 1, 2023 and a ceiling value of $1,052.76. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,702.60, is for the delivery of TELMISARTAN 20 MG TABLET 30S, a cardiovascular medication. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of July 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,040.98 and covers the delivery of TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award, valued at $4,103.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4560923528 - TELMISARTAN 40 MG TABLET 30S. The contract has a period of performance through May 15, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.02, is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to the prime contractor Amerisourcebergen Drug Corp. The $2,004.92 firm fixed-price delivery order is for the supply of 4562569054 - TELMISARTAN 80 MG TABLET 30S, with a completion date of October 24, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with a ceiling value of $4,607.15, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,021,832 Telmisartan 20 mg tablets in units of 30. This contract is a delivery order and has a firm fixed price pricing type, with a completion date of December 8, 2023. The award was made on December 7, 2022, and there was no set-aside designation used....
This federal contract award, valued at $1,424.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, is for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. This contract does not have a set-aside designation, indicating open...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB23FZ3S9
    Delivery Order

This federal contract award, valued at $6,699.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560607919 - TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2023 and is a Firm Fixed Price Delivery Order. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/9/25, 10:20 AM